Pharmaceutical News

RSS

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017

Making doctors check patients' drug history could be simple way to reduce opioid epidemic

There's a simple way to reduce the opioid epidemic gripping the country, according to new Cornell University research: Make doctors check their patients' previous prescriptions.

2 May 2017

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Surgery and radiation remove, kill, or damage cancer cells in a certain area. But chemotherapy -- which uses medicines or drugs to treat cancer -- can work throughout the whole body, killing cancer cells that have spread far from the original tumor.

2 May 2017

New chiral molecular sieves may lead to production of better drugs

An international team of researchers, led by Mark E. Davis at Caltech, has succeeded in making the first chiral molecular sieves. This discovery opens new areas of investigation in both chemistry and biology, and has broad implications for pharmaceutical companies and other specialized chemical manufacturers.

2 May 2017

Adjusting dose of psychiatric drugs could reduce fall risk among elderly people

Simply adjusting the dose of an older adult's psychiatric medication could reduce their risk of falling, a new University of Michigan study suggests.

2 May 2017

Powerful pain medicine may help reduce vision damage of glaucoma

The tip of our optic nerve is typically the first place injured by glaucoma. Now researchers want to know if the powerful pain medicine (+)-pentazocine can help avoid the damage.

2 May 2017

Low-cost drug for severe bleeding could save lives of mothers after childbirth

An inexpensive and widely available drug could save the lives of one in three mothers who would otherwise bleed to death after childbirth, according to a major study published in The Lancet. The global trial of 20,000 women found that death due to bleeding was reduced by 31% if the treatment was given within three hours.

29 Apr 2017

China creates new kinase-based whole-cell screening library for high-throughput drug assay

After five years of hard work, China has completed the world's largest kinase-based whole-cell screening library for high-throughput drug assay.

28 Apr 2017

Study highlights importance of educating family members on opioid overdoses and naloxone use

Family members are often the ones who administer naloxone during an opioid overdose and should be considered as part of the larger response to help curb fatal overdoses.

28 Apr 2017

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.

28 Apr 2017

Cheaper topical steroids could lead to potential health care and out-of-pocket savings

Although topical steroids are among the most commonly prescribed medications by dermatologists, there are limited data on spending and use for this class of drugs.

28 Apr 2017

Study shows how antibiotic treatments may offset beneficial effects of whole grain intake

According to recommendations from the Danish Veterinary and Food Administration, adult Danes should consume at least 75 g whole meal a day.

28 Apr 2017

Stivarga receives expanded FDA approval for treatment of liver cancer

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.

28 Apr 2017

FDA approves first drug for treating rare form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

27 Apr 2017

Nose2Brain project aims to develop better therapy for multiple sclerosis

Medically active substances are normally distributed via the blood - either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration.

27 Apr 2017

Study findings provide insights into pharmacophobia

In the current issue of Psychotherapy and Psychosomatics the attitudes of patients toward medication are analyzed, with special reference to pharmacophobia.

27 Apr 2017

Antidepressant improves drug delivery across the blood-brain barrier, rat study shows

NIH rat study suggests amitriptyline temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain.

27 Apr 2017

Study finds increase in illicit cannabis use and disorders after states passed medical marijuana laws

Illicit cannabis use and cannabis use disorders increased at a greater rate in states that passed medical marijuana laws than in other states, according to new research at Columbia University's Mailman School of Public Health and Columbia University Medical Center.

27 Apr 2017

Researchers aim to test asthma drug for treating patients with heart disease

Researchers at Guy's and St Thomas' NHS Foundation Trust have launched an innovative new trial which aims to improve the recovery of patients with serious heart conditions.

27 Apr 2017

Research offers new way to improve nanopharmaceuticals for personalized medicine

In a newly published study in Nature Nanotechnology, the shape and geometry of nanoparticles can have a significant impact in modulating adverse injection reactions and offer realistic solutions for patients receiving nanopharmaceuticals—drug delivery systems specializing in microscopic-particle drug combinations.

27 Apr 2017

Pharmaceutical News

Infantile spasms and multiple sclerosis relapse data presented at AAN

Making doctors check patients' drug history could be simple way to reduce opioid epidemic

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

New chiral molecular sieves may lead to production of better drugs

Adjusting dose of psychiatric drugs could reduce fall risk among elderly people

Powerful pain medicine may help reduce vision damage of glaucoma

Low-cost drug for severe bleeding could save lives of mothers after childbirth

China creates new kinase-based whole-cell screening library for high-throughput drug assay

Study highlights importance of educating family members on opioid overdoses and naloxone use

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Cheaper topical steroids could lead to potential health care and out-of-pocket savings

Study shows how antibiotic treatments may offset beneficial effects of whole grain intake

Stivarga receives expanded FDA approval for treatment of liver cancer

FDA approves first drug for treating rare form of Batten disease

Nose2Brain project aims to develop better therapy for multiple sclerosis

Study findings provide insights into pharmacophobia

Antidepressant improves drug delivery across the blood-brain barrier, rat study shows

Study finds increase in illicit cannabis use and disorders after states passed medical marijuana laws

Researchers aim to test asthma drug for treating patients with heart disease

Research offers new way to improve nanopharmaceuticals for personalized medicine

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News